ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: SA-PO957

Protective Effect of COMP-Angiopoietin 1 on Peritoneal Vascular Permeability and Peritoneal Transport Function in Uremic Peritoneal Dialysis Rats

Session Information

Category: Dialysis

  • 703 Dialysis: Peritoneal Dialysis


  • Shi, Yuanyuan, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China

The angiopoietin-1 (Ang-1)/Tie-2 signaling pathway plays a crucial role in the maintenance of vascular stabilization and permeability.


Thirty-six male Sprague-Dawley rats were randomly assigned to the sham operation group, uremia group or uremia+PD group (each n=12). Then, COMP-Ang-1 adenovirus or vehicle adenovirus was injected into twenty other uremic PD rats via the tail vein (each n=10). A peritoneal equilibration test (PET) was performed to evaluate peritoneal transport function before the rats were euthanized. Peritoneal vascular permeability was assessed by measuring FITC-dextran (4 kDa) and FITC-BSA (69 kDa) leakage. The pericyte coverage rate was quantified by anti-CD31 and anti-Desmin immunofluorescence staining. Expression of endothelial junction proteins and Ang-1/Tie-2 signaling were examined by western blotting. The levels of proinflammatory adhesion molecules and cytokines in the peritoneum were measured by real-time quantitative polymerase chain reaction (PCR).


Compared to the sham controls, uremic rats were characterized by decreased pericyte coverage, downregulated endothelial junction protein expression and increased FITC-BSA and FITC-dextran leakage, accompanied by increased levels of proinflammatory adhesion molecules and cytokines, increased D/Pcr and decreased ultrafiltration. After infusion of PDF for 4 weeks, more marked changes were noted. Peritoneal Ang-1 protein expression and Tie-2 phosphorylation were significantly lower in uremic rats than in control rats and were further significantly reduced in uremia+PD rats. After COMP-Ang-1 administration, phosphorylation of the Tie-2 receptor was significantly increased. Treatment with COMP-Ang-1 also significantly enhanced pericyte coverage, upregulated endothelial junctions expression and inhibited the leakage of FITC-BSA and FITC-dextran from the peritoneal vasculature induced during PD therapy; these changes were accompanied by reduced peritoneal tissue levels of proinflammatory adhesion molecules and cytokines, decreased D/Pcr and increased ultrafiltration.


COMP-Ang-1 exerts a protective effect against damage-induced peritoneal vascular permeability and inflammation at least in part by enhancing pericyte coverage and endothelial junction protein expression, which subsequently significantly improves peritoneal transport function.